Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | TUBB1 | Q9H4B7 | 5/20 | 0.48 |
| ▸ | KDM1A | O60341 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.40 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.40 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.40 |
| ▸ | ERN1 | O75460 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8080493 | 0.82 | AMY1A (0.40) | RAB9ALMNAMAPK1HTTALDH1A1 | |
| SCHEMBL5237640 | 0.78 | CA2 (0.54) | MAPK1TUBB1ALDH1A1 | |
| SCHEMBL13088885 | 0.78 | KDM1A (0.34) | RAB9ALMNAMAPK1HTTTUBB1 | |
| SCHEMBL23602742 | 0.77 | KCNQ3 (0.39) | MEN1KMT2A | |
| SCHEMBL12801465 | 0.77 | KDM1A (0.50) | RAB9AMAPK1HTTTUBB1KDM1A | |
| SCHEMBL197204 | 0.76 | LMNA (0.53) | RAB9ALMNAMAPK1HTTTUBB1 | |
| SCHEMBL29366053 | 0.76 | LMNA (0.53) | RAB9ALMNAMAPK1HTTTUBB1 | |
| SCHEMBL9464193 | 0.76 | CYP17A1 (0.61) | RAB9ALMNAMAPK1HTTTUBB1 | |
| SCHEMBL8232426 | 0.76 | ACHE (0.46) | LMNAALDH1A1SMN1; SMN2PDGFRBPDGFRA | |
| Water SCHEMBL27700275 | 0.76 | CA2 (0.52) | MAPK1TUBB1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3889132-A1 | MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS | Università di Pisa (IT) | 2021-10-06 | — | — | EP | disclosed |
| EP-2927219-B1 | 2-ARYL SELENAZOLE COMPOUND AND PHARMACEUTICAL COMPOSITION THEREOF | ATOM BIOSCIENCE AND PHARMACEUTICAL CO LTD (CN) | 2018-05-30 | — | — | EP | disclosed |
| WO-2013119916-A2 | COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY | PTC THERAPEUTICS, INC. (US) | 2013-08-15 | — | — | WO | disclosed |
| US-20120015966-A1 | PPAR ACTIVE COMPOUNDS | PLEXXIKON INC | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120015966-A1 | PPAR ACTIVE COMPOUNDS | PPARG, PPARA, PPARD | RAB9A 3520/4885LMNA 1815/4885MAPK1 2193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.